Cargando…

RHBDF2 gene functions are correlated to facilitated renal clear cell carcinoma progression

BACKGROUND: The rhomboids are a family of multi-transmembrane proteins, many of which have been implicated in facilitating tumor progression. Little is yet known, however, about rhomboid-associated biomarkers in cancers. An analysis of such biomarkers could yield important insights into the role of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Lei, Liu, Xiu-Xiu, Yang, Yu-Meng, Wang, Yan, Song, Yuan-Yuan, Gao, Shan, Li, Lu-Yuan, Zhang, Zhi-Song
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Primary Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8567583/ https://www.ncbi.nlm.nih.gov/pubmed/34736454 http://dx.doi.org/10.1186/s12935-021-02277-0

Ejemplares similares

RHBDF1 promotes AP-1-activated endothelial–mesenchymal transition in tumor fibrotic stroma formation
por: Gao, Shan, et al.
Publicado: (2021)

LRRK2 is a candidate prognostic biomarker for clear cell renal cell carcinoma
por: Yang, Chunxiu, et al.
Publicado: (2021)

SNORD63 and SNORD96A as the non-invasive diagnostic biomarkers for clear cell renal cell carcinoma
por: Shang, Xiaoling, et al.
Publicado: (2021)

Inhibition of KIF20A by transcription factor IRF6 affects the progression of renal clear cell carcinoma
por: Ma, Xinwei, et al.
Publicado: (2021)

RHBDF2 is correlated with immune infiltrates in hepatocellular carcinoma and may have potential as a biomarker
por: Gong, Hanjuan, et al.
Publicado: (2023)

Inactive rhomboid proteins RHBDF1 and RHBDF2 (iRhoms): a decade of research in murine models
por: Burzenski, Lisa M., et al.
Publicado: (2021)

TRIM47 promotes malignant progression of renal cell carcinoma by degrading P53 through ubiquitination
por: Chen, Jia-xin, et al.
Publicado: (2021)

Upregulation of ARNTL2 is associated with poor survival and immune infiltration in clear cell renal cell carcinoma
por: Wang, Song, et al.
Publicado: (2021)

Epigenetic signature predicts overall survival clear cell renal cell carcinoma
por: Wang, Yejinpeng, et al.
Publicado: (2020)

Development and validation of ferroptosis-related lncRNAs prognosis signatures in kidney renal clear cell carcinoma
por: Xing, Xiao-Liang, et al.
Publicado: (2021)

Pseudogene HSPA7 is a poor prognostic biomarker in Kidney Renal Clear Cell Carcinoma (KIRC) and correlated with immune infiltrates
por: Ding, Chunjin, et al.
Publicado: (2021)

AGAP2-AS1 as a prognostic biomarker in low-risk clear cell renal cell carcinoma patients with progressing disease
por: Nakken, Sigrid, et al.
Publicado: (2021)

Identification of a three-long noncoding RNA prognostic model involved competitive endogenous RNA in kidney renal clear cell carcinoma
por: Zhang, Di, et al.
Publicado: (2020)

Bioinformatic analysis identifying FGF1 gene as a new prognostic indicator in clear cell Renal Cell Carcinoma
por: Zhang, Xiaoqin, et al.
Publicado: (2021)

Comprehensive analysis of pyroptosis regulators and tumor immune microenvironment in clear cell renal cell carcinoma
por: Zhang, Yan, et al.
Publicado: (2021)

Down-regulation of BCL2L13 renders poor prognosis in clear cell and papillary renal cell carcinoma
por: Meng, Fei, et al.
Publicado: (2021)

CTLA4 has a profound impact on the landscape of tumor-infiltrating lymphocytes with a high prognosis value in clear cell renal cell carcinoma (ccRCC)
por: Liu, Shiyi, et al.
Publicado: (2020)

Construction of a novel gene-based model for prognosis prediction of clear cell renal cell carcinoma
por: Zhang, Zedan, et al.
Publicado: (2020)

Identification of biological targets of therapeutic intervention for clear cell renal cell carcinoma based on bioinformatics approach
por: Chen, Yongsheng, et al.
Publicado: (2016)

miR-198 inhibits the progression of renal cell carcinoma by targeting BIRC5
por: Yuan, Chao, et al.
Publicado: (2021)

miR-129-5p inhibits clear cell renal cell carcinoma cell proliferation, migration and invasion by targeting SPN
por: Gao, Bin, et al.
Publicado: (2021)

Overexpression of HHLA2 in human clear cell renal cell carcinoma is significantly associated with poor survival of the patients
por: Chen, Lujun, et al.
Publicado: (2019)

Myc-associated zinc-finger protein promotes clear cell renal cell carcinoma progression through transcriptional activation of the MAP2K2-dependent ERK pathway
por: Ren, Li-Xin, et al.
Publicado: (2021)

Construction and validation of a ferroptosis-related long noncoding RNA signature in clear cell renal cell carcinoma
por: Zhu, Zhenpeng, et al.
Publicado: (2022)

Transcriptomic characterization and innovative molecular classification of clear cell renal cell carcinoma in the Chinese population
por: Zhao, Qiang, et al.
Publicado: (2020)

A nomogram based on 9-lncRNAs signature for improving prognostic prediction of clear cell renal cell carcinoma
por: Jiang, Wen, et al.
Publicado: (2019)

High expression of CDCA7 predicts poor prognosis for clear cell renal cell carcinoma and explores its associations with immunity
por: Liu, Shouyong, et al.
Publicado: (2021)

LPCAT1 overexpression promotes the progression of hepatocellular carcinoma
por: He, Rong-Quan, et al.
Publicado: (2021)

Decreased expression of METTL14 predicts poor prognosis and construction of a prognostic signature for clear cell renal cell carcinoma
por: Wang, Yi, et al.
Publicado: (2021)

The immune‐related biomarker TEK inhibits the development of clear cell renal cell carcinoma (ccRCC) by regulating AKT phosphorylation
por: Chen, Siming, et al.
Publicado: (2021)

Collagen-Induced Arthritis Analysis in Rhbdf2 Knockout Mouse
por: Lee, Min-Young, et al.
Publicado: (2018)

TRPM2 facilitates tumor progression of clear cell renal cell carcinoma by relieving Endoplasmic Reticulum Stress
por: Yuan, Hongwei, et al.
Publicado: (2023)

Development and validation of a VHL-associated immune prognostic signature for clear cell renal cell carcinoma
por: Zhang, Jin, et al.
Publicado: (2020)

Establishment and characterization of clear cell renal cell carcinoma cell lines with different metastatic potential from Chinese patients
por: Tan, Xiaojie, et al.
Publicado: (2013)

miR-363 suppresses the proliferation, migration and invasion of clear cell renal cell carcinoma by downregulating S1PR1
por: Xie, Yongpeng, et al.
Publicado: (2020)

Abnormal expression and prognostic significance of EPB41L1 in kidney renal clear cell carcinoma based on data mining
por: Liang, Taotao, et al.
Publicado: (2020)

USP39 promotes malignant proliferation and angiogenesis of renal cell carcinoma by inhibiting VEGF-A(165b) alternative splicing via regulating SRSF1 and SRPK1
por: Pan, Xiu-wu, et al.
Publicado: (2021)

LncRNA-LET inhibits cell growth of clear cell renal cell carcinoma by regulating miR-373-3p
por: Ye, Zhuo, et al.
Publicado: (2019)

As a prognostic biomarker of clear cell renal cell carcinoma RUFY4 predicts immunotherapy responsiveness in a PDL1-related manner
por: Miao, Daojia, et al.
Publicado: (2022)

LINC01128 facilitates the progression of pancreatic cancer through up-regulation of LDHA by targeting miR-561-5p
por: Zhong, Min, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rrfldbugvni1d9d14asm0gq79b